Jennison Associates’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $1.05M | Buy |
|
|||||
|
2024
Q1 | $1.19M | Sell |
|
|||||
|
2023
Q4 | $1.1M | Sell |
|
|||||
|
2023
Q3 | $34.1M | Sell |
|
|||||
|
2023
Q2 | $52.8M | Buy |
|
|||||
|
2023
Q1 | $51M | Buy |
|
|||||
|
2022
Q4 | $58.6M | Buy |
|
|||||
|
2022
Q3 | $39.6M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $4.65M | Sell |
|
|||||
|
2017
Q3 | $11.1M | Sell |
|
|||||
|
2017
Q2 | $13.3M | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $672K | Sell |
|
|||||
|
2016
Q3 | $5.82M | Sell |
|
|||||
|
2016
Q2 | $5.25M | Buy |
|
|||||
|
2016
Q1 | $5.98M | Buy |
|